secwatch.observer — SEC 8-K summary
======================================

Issuer:     KALA BIO, Inc. (KALA)
CIK:        0001479419
Form:       8-K
Filed at:   2026-02-02T23:59:59+00:00
Accession:  0001829126-26-000837
Event type: m_and_a
Sentiment:  negative
Materiality: 0.90
Item codes: 1.01, 3.02, 5.01, 5.02, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

KALA BIO sells $4.2M Series AAA Preferred, board control shifts to AK Holdings
------------------------------------------------------------------------------

- Company issued 2.1M shares of Series AAA Preferred at $2/sh, raising $4.2M; each share convertible into 420 common shares (882M total potential shares).
- AK Holdings appointed five directors: Avi Minkowitz, Hillel Posen, Chaim Berger, Yonatan Colman, Brendan Purdy, replacing prior board.
- Stockholders approved increase in authorized common shares to 1.5B and authorized reverse stock split (1:2 to 1:100).
- Six prior directors resigned (Marjan Farid, Andrew Koven, Mark Iwicki, Todd Bazemore, C. Daniel Meyers, Howard Rosen).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479419/000182912626000837/0001829126-26-000837-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479419/000182912626000837/kalabio_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-26-000837

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer